RACHEL MATHISEN: Open Payments
NPI 1174138887 · HENDERSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,414 in 78 payments from 18 companies in 2025. Trend: 2023 $1,007 · 2024 $688 · 2025 $1,414
Food & beverage: $1,414
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $264 |
| Otsuka America Pharmaceutical, Inc. | 10 | $222 |
| Novo Nordisk Inc | 6 | $117 |
| Teva Pharmaceuticals USA, Inc. | 5 | $99 |
| AstraZeneca Pharmaceuticals LP | 6 | $98 |
| GlaxoSmithKline, LLC. | 5 | $97 |
| Lilly USA, LLC | 5 | $95 |
| Amgen Inc. | 5 | $84 |
| PFIZER INC. | 3 | $52 |
| Exact Sciences Corporation | 3 | $51 |
Products named: REXULTI, QULIPTA, AUSTEDO XR, TRELEGY ELLIPTA, UBRELVY, VRAYLAR, Wegovy, MOUNJARO.
Industry payments across NC — which companies pay providers there.
